Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
44

Summary

Conditions
  • Immunization
  • Vaccination
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Cluster RCT study design will test the impact of the bundle (communication still training, performance feedback and prompts) to reduce missed opportunities and raise HPV vaccine rates.Masking: None (Open Label)Primary Purpose: Health Services Research

Participation Requirements

Age
Between 11 years and 17 years
Gender
Both males and females

Description

HPV vaccine rates remain lower than rates for other adolescent vaccines. Missed opportunities (MOs) are healthcare visits during which a patient is eligible, but does not receive a vaccine. MOs for vaccination contribute strongly to low HPV vaccination rates. This cluster randomized clinical trial w...

HPV vaccine rates remain lower than rates for other adolescent vaccines. Missed opportunities (MOs) are healthcare visits during which a patient is eligible, but does not receive a vaccine. MOs for vaccination contribute strongly to low HPV vaccination rates. This cluster randomized clinical trial will test the effectiveness (and cost-effectiveness) of a bundled intervention training providers first in HPV vaccine communication skills (done through online educational modules and live office practice sessions), with the addition of performance feedback reports (that pull from electronic health record (EHR) data, and compare participants' performance to their own previous performance and performance of others) followed by the addition of provider prompts (via EHR and also office staff prompts, e.g., placing Vaccine Information Statements (VISs) on desk) to reduce MOs and increase HPV vaccination rates. Throughout the intervention participants will also receive weekly text message mini-lessons that will remind participants of the project.

Tracking Information

NCT #
NCT03609242
Collaborators
  • Children's Hospital of Philadelphia
  • American Academy of Pediatrics
  • University of Pennsylvania
  • National Institutes of Health (NIH)
  • National Cancer Institute (NCI)
  • University of Rochester
Investigators
Principal Investigator: Peter Szilagyi, MD University of California, Los Angeles